ROBERT M. NALBANDIAN, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The recent letter of Drs. Rudders and Pisciotta (Ann Intern Med 77:659-660, 1972) sets forth their understandable demurral on urea therapy in sickle-cell disease. Our views can be supported by documentation from current literature.
Independent reports of the successful use of oral urea therapy are now available. Targino de Araujo, Wronowski, and Cimino (1) managed 20 patients on oral urea, with 20 controls. They noted that all 20 of the treated patients, previously refractory to other therapeutic regimens, "presented marked clinical improvement." Also, they found evidence of increased hemoglobin synthesis in 4 of the 20 treated patients.
NALBANDIAN RM. Urea Therapy in Sickle-Cell Disease. Ann Intern Med. ;78:312. doi: 10.7326/0003-4819-78-2-312_1
Download citation file:
Published: Ann Intern Med. 1973;78(2):312.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use